Audrey Li, MD
Assistant Professor, Medicine
Biography
I’m currently an infectious disease attending physician at Boston Medical Center, with rank of assistant professor at Boston University School of Medicine. My passions are in health inequities, health justice, and care for the underserved. I have a special interest in the interface of infectious diseases and addiction medicine, both clinically and in terms of research and advocacy.
Websites
Education
- State University of New York at Stony Brook, MD
- Princeton University, AB
Classes Taught
Publications
- Published on 1/1/2021
Rowley CF & Li A. “Opioid Use Disorder and Endocarditis.” In B Norton (Ed.). The Opioid Epidemic and Infectious Diseases, 1e. Elsevier. New York. 2021; 125-160.
- Published on 1/1/2020
Li A, Rosenthal ES, Rapoport AB, Rowley CF. Opioid use disorder and infectious complications in persons who inject drugs. Int Anesthesiol Clin. 2020; 58(2):4-11. PMID: 32073421.
Read at: PubMed - Published on 1/1/2019
Eilertson B, Chen L, Li A, Chavda KD, Chavda B, Kreiswirth BN. CG258 Klebsiella pneumoniae isolates without ß-lactam resistance at the onset of the carbapenem-resistant Enterobacteriaceae epidemic in New York City. J Antimicrob Chemother. 2019 Jan 01; 74(1):17-21. PMID: 30272172.
Read at: PubMed - Published on 2/12/2014
French AS, Li AW, Meisner S, Torkkeli PH. Upstream open reading frames and Kozak regions of assembled transcriptome sequences from the spider Cupiennius salei. Selection or chance? Gene. 2014 Apr 15; 539(2):203-8. PMID: 24530309.
Read at: PubMed - Published on 3/1/2010
O'Blenes SB, Li AW, Chen R, Arora RC, Horackova M. Engraftment is optimal when myoblasts are transplanted early: the role of hepatocyte growth factor. Ann Thorac Surg. 2010 Mar; 89(3):829-35. PMID: 20172138.
Read at: PubMed - Published on 12/1/2007
Baguma-Nibasheka M, Barclay C, Li AW, Geldenhuys L, Porter GA, Blay J, Casson AG, Murphy PR. Selective cyclooxygenase-2 inhibition suppresses basic fibroblast growth factor expression in human esophageal adenocarcinoma. Mol Carcinog. 2007 Dec; 46(12):971-80. PMID: 17477358.
Read at: PubMed - Published on 1/21/2007
Baguma-Nibasheka M, Li AW, Murphy PR. The fibroblast growth factor-2 antisense gene inhibits nuclear accumulation of FGF-2 and delays cell cycle progression in C6 glioma cells. Mol Cell Endocrinol. 2007 Mar 15; 267(1-2):127-36. PMID: 17306451.
Read at: PubMed - Published on 11/1/2005
Barclay C, Li AW, Geldenhuys L, Baguma-Nibasheka M, Porter GA, Veugelers PJ, Murphy PR, Casson AG. Basic fibroblast growth factor (FGF-2) overexpression is a risk factor for esophageal cancer recurrence and reduced survival, which is ameliorated by coexpression of the FGF-2 antisense gene. Clin Cancer Res. 2005 Nov 01; 11(21):7683-91. PMID: 16278388.
Read at: PubMed - Published on 12/30/2004
Baguma-Nibasheka M, Li AW, Osman MS, Geldenhuys L, Casson AG, Too CK, Murphy PR. Coexpression and regulation of the FGF-2 and FGF antisense genes in leukemic cells. Leuk Res. 2005 Apr; 29(4):423-33. PMID: 15725477.
Read at: PubMed - Published on 9/1/2002
Yamada M, Li AW, West KA, Chang CH, Wall JR. Experimental model for ophthalmopathy in BALB/c and outbred (CD-1) mice genetically immunized with G2s and the thyrotropin receptor. Autoimmunity. 2002 Sep; 35(6):403-13. PMID: 12568121.
Read at: PubMed
View 1 more publications: View full profile at BUMC